Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Incyte Corp shares valued at $45,310 were sold by Denton Sheila A. on Aug 04 ’25. At $75.77 per share, Denton Sheila A. sold 598 shares. The insider’s holdings dropped to 33,200 shares worth approximately $2.6 million following the completion of this transaction.
Also, SHEILA DENTON purchased 598 shares, netting a total of over 45,310 in proceeds.
Before that, Stein Steven H had sold 3,706 shares from its account. In a trade valued at $251,786, the EVP & Chief Medical Officer traded Incyte Corp shares for $67.94 each. Upon closing the transaction, the insider’s holdings decreased to 3,706 shares, worth approximately $8.05 million.
As published in a research note from Wells Fargo on August 06, 2025, Incyte Corp [INCY] has been rated up from an Equal weight to an Overweight and the price target has been revised to $89. Analysts at Barclays started covering the stock with ‘”an Overweight”‘ outlook in a report released in early August. As of June 16, 2025, Stifel has increased its “Hold” rating to a “Buy” for INCY. Earlier on March 18, 2025, William Blair downgraded its rating. Their new recommendation was “a Mkt perform” for INCY stock which previously was a “an Outperform”.
Analyzing INCY Stock Performance
On last trading session, Incyte Corp [NASDAQ: INCY] rose 0.71% to $78.2. The stock’s lowest price that day was $76.79, but it reached a high of $78.25 in the same session. During the last five days, there has been a surge of approximately 4.42%. Over the course of the year, Incyte Corp shares have jumped approximately 26.13%.
Is Incyte Corp subject to short interest?
Stocks of Incyte Corp saw a sharp steep in short interest on 2025-07-15 dropping by -1.07 million shares to 7.12 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 8.19 million shares. A decline of -14.99% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.84 of the overall float, the days-to-cover ratio (short ratio) decline to 3.84.
Which companies own the most shares of Incyte Corp (INCY)?
In terms of Incyte Corp share price expectations, FactSet research, analysts set an average price target of 68 in the next 12 months, down nearly -12.43% from the previous closing price of $77.65. Analysts anticipate Incyte Corp stock to reach 92 by 2025, with the lowest price target being 67. In spite of this, 12 analysts ranked Incyte Corp stock as Buy at the end of 2025.
